This website is intended for UK healthcare professionals only Log in | Register

Editorial articles

July 2004 Br J Cardiol (Acute Interv Cardiol) 2004;11:AIC 35–AIC 37

Follow-on angioplasty via the radial artery – a personal view

Nicholas MK Robinson

Abstract

The benefits of transradial coronary intervention (TRI)
over transfemoral (TFI) are becoming increasingly
recognised. In the United Kingdom, an increasing
number of interventions are being performed by the radial
approach and courses supporting this approach are now well
developed.

| Full text

July 2004 Br J Cardiol (Acute Interv Cardiol) 2004;11:AIC 38–AIC 40

Statin therapy following percutaneous coronary revascularisation: time to make LIPS stick?

Arun Natarajan, Scott A Gall, Azfar Zaman

Abstract

The success of the 3-hydroxy-3-methylglutaryl-coenzyme
A reductase inhibitors (statins) in ameliorating
atherothrombotic events is firmly established. Large
randomised controlled clinical trials have consistently (and
unequivocally) demonstrated a beneficial role in reducing
coronary events and total mortality in patients with advanced
coronary artery disease (CAD).

| Full text

July 2004 Br J Cardiol 2004;11:261-2

Living with an ICD – the price of saving a life

Violet R Henry, Sharon Smart, Salma Akram, Katherine McGrath, Ian Wright, Sophie Blackman, Nicholas S Peters

Abstract

Most treatments administered to patients act to relieve symptoms. But in the name of saving life,
having an implanted cardioverter defibrillator (ICD) leaves the patient prone to unpredictable episodes of
symptoms including collapse, and abrupt and explosive chest pain, of which the informed patient may live in
persistent fear.

| Full text

May 2004 Br J Cardiol 2004;11:175-8

General practitioners with a special interest

David Fitzmaurice

Abstract

Despite many attempts at reform, there has been a persistent
shortfall in the number of consultant cardiologists.
As long ago as 1985, the conservative recommendation
was made that each general hospital should have
at least one physician, practising general medicine but
having a special expertise and training in cardiology.

| Full text

March 2004 Br J Cardiol 2004;11:93

OTC statins – an ethical test case

Peter Stott

Abstract

Statins are currently provided at NHS expense for patients
with coronary heart disease (CHD), diabetes and those
whose coronary risk is greater than 3% per year.

| Full text

March 2004 Br J Cardiol 2004;11:89-91

OTC statins: the implications for primary prevention in the UK

Rubin Minhas

Abstract

The difficulty in delivering a viable primary prevention
policy has been evident ever since the publication of
the National Service Framework for Coronary Heart
Disease (NSF-CHD).

| Full text

March 2004 Br J Cardiol (Acute Interv Cardiol) 2004;11:AIC 3–AIC 6

Cardiac enzyme release following percutaneous coronary intervention

Jason Causer, Martyn Wood, Rodney H Stables

Abstract

The measurement of biochemical markers of myocardial cell damage is a key component of modern cardiology practice. The use of these tests in the diagnosis of myocardial infarction (MI) has been routine for three decades, with the measurement of serum levels of creatine kinase (CK) and its myocardial band isofraction (CK-MB) emerging as the traditional standard in this respect.

| Full text

March 2004 Br J Cardiol (Acute Interv Cardiol) 2004;11:AIC 7

A good thing after all? Raised cardiac enzymes after PCI

Nick Curzen

Abstract

In this issue of Acute and Interventional Cardiology there is a commissioned editorial about the release of cardiac enzymes after percutaneous coronary intervention (PCI). This remains a contentious area and attracts the views of two opposing schools of thought.

| Full text

January 2004 Br J Cardiol 2004;11:22-3

Heart failure beyond maximum medical management

Jeremy Bray

Abstract

The management of advanced heart failure when medical treatment alone is no longer sufficient was the focus of the 2003 British Society for Heart Failure (BSH) annual autumn meeting, held in Oxford on 28 November.

| Full text

January 2004 Br J Cardiol 2004;11:16-21

Omega-3 polyunsaturated fatty acids: mechanisms and clinical applications explored

BJCardio editorial team

Abstract

A joint British Journal of Cardiology and H.E.A.R.T UK round table meeting held at the National Heart and Lung Institute, 18th November 2003.

| Full text

Advertisement

For healthcare professionals only

Advertisement

For healthcare professionals only

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now